ghk cu reta mt2 here's what you missedππΎ #peptides , 1οΈβ£ R3tatrutide, βImagine a coach Unlicensed weight-loss drugs marketed on
Description
Retatrutide achieves 24.2% weight loss in clinical trials, beating Ozempic (14.9%) and Mounjaro (20.9%)
Results may vary, and its important to consult a qualified professional to determine if this treatment suits you
, Kolenc, D
While CJC-1295 W/O DAC lasts about 30 minutes, this version stays active for roughly 68 days in certain preclinical models
Since the drug targets multiple metabolic pathways and has shown impressive early trial outcomes, it is on the news and trials seem to be going in its favour
